| Price | $0.41 |
| Year Range | $0.32 – $4.74 |
| Market Cap | $3.7M |
| Industry | Medical Devices |
What Is ENvue Medical’s AI Stock Analysis?
ENvue Medical’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks ENvue Medical’s momentum in near-real time.
ENvue Medical (FEED) has an AltIndex AI Score of 46/100, currently a Hold signal. The AI Score distills ENvue Medical's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
ENvue Medical’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of ENvue Medical — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving FEED’s AI Score?
Fundamentals
Revenue for the last quarter was $310,000. This represents a decrease of 56.79% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 29.73%, which may be a cause for concern. Net income for the last quarter was $-13M. This represents a decrease of 2,242.00% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 798.11%, which may be a cause for concern. Ebitda for the last quarter was $-5.9M. This represents a decrease of 788.07% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 312.55%, which may be a cause for concern.
See ENvue Medical’s earnings and insider transactions.
Technicals
Today's stock price is $0.41. This represents a decrease of 22.64% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 94.69%, which could be a cause for long-term concern. The trend is bullish. The current SMA10 is $0.37, which is higher than the previous SMA10 of $0.36. This indicates a potential upward trend in price movement. The RSI is 28.4, indicating a potentially oversold (bullish) condition.
See the full technical analysis and price prediction.
Alternative data
ENvue Medical has an estimate of 2,000 visitors to their webpage. The number of visitors is down by -33% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore ENvue Medical’s job postings, web traffic and app downloads.
Frequently Asked Questions: ENvue Medical AI Stock Analysis
ENvue Medical's AltIndex AI Score is 46/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates ENvue Medical a Hold (46/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of ENvue Medical — company overview, fundamentals, technicals and alternative data, with a recommendation. See the FEED AI Score or sign up to read the full thesis.
